Excessive use of reliever inhalers for asthma is linked to a significantly increased risk of dying from the disease, a new study revealed today. Researchers found that over-use of short acting ...

This inhaler contains 3 medications: budesonide, glycopyrrolate, and formoterol. Budesonide works by reducing the irritation and swelling of the airways. Budesonide belongs to a class of drugs ...

Inhaler: peak plasma concentrations of 49ng/mL reached within 15 minutes. Nasal spray: maximum venous concentrations of 2–12ng/mL reached in 4–15 minutes. Nasal Spray antagonized by nasal ...

A salt pipe is an inhaler containing salt particles. Advocates of salt pipes suggest they help with many health conditions, including asthma, but scientific support is limited. Salt therapy ...

Approximately two thirds of hospitalized adults with chronic obstructive pulmonary disease (COPD) received suboptimal treatment with inhalers, mainly resulting from errors, based on data from 96 ...

Asthma medications are usually taken by breathing them in using an inhaler or nebulizer. This allows the medicine to go directly into your lungs. When you have a flare-up, quick-relief medicines ...

Philip Morris International Inc is selling Vectura Group Ltd. for roughly a third of the price it paid for the UK maker of asthma inhalers about three years ago. The tobacco company said Tuesday ...

Polluting Puff: Asthma Inhalers Are Big Contributors to Climate Change By Dennis Thompson HealthDay Reporter MONDAY, Sept. 16, 2024 (HealthDay News) -- Tiny puffs from asthma inhalers could be ...

It's because some inhalers release greenhouse gases linked to global warming. But the Cambridge University team told BMJ Open patients must check with a doctor before changing medication.

Desiree DeNunzio is the gift guide editor for CNET's Commerce team. When she's not writing and editing, she's either hiking through the redwoods or curled up with a good book and a lazy dog ...

Model year 2015 brought another redesign. While it represents a vast improvement over the 2011 model, the 200 continues to trail the field by a considerable margin. This is largely owing to klutzy ...

However, the Street-high price target of $200 suggests that Nvidia stock could jump another 71% over the next year. Here's why this semiconductor company's shares could hit that mark in 2025.